- Danat Al Emarat Hospital for Women & Children demonstrates success in using Teplizumab for Type 1 diabetes treatment in the UAE and wider region
- Teplizumab is an immunotherapy drug designed to delay the onset of Type 1 diabetes (T1D) in those  who have a confirmed diagnosis of T1D without clinical symptoms, as determined through the assessment of beta-cell function
- It is one of the biggest treatment breakthroughs for the chronic condition since the discovery of insulin more than 100 years ago
